<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Clin Biochem Nutr</journal-id><journal-id journal-id-type="publisher-id">JCBN</journal-id><journal-title>Journal of Clinical Biochemistry and Nutrition</journal-title><issn pub-type="ppub">0912-0009</issn><issn pub-type="epub">1880-5086</issn><publisher><publisher-name>the Society for Free Radical Research Japan</publisher-name><publisher-loc>Kyoto, Japan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">jcbn2007008</article-id><article-id pub-id-type="doi">10.3164/jcbn.40.62</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Absence of Common Polymorphisms of Toll Like Receptor 4 (TLR4): Asp299Gly, Thr399Ile in Patients with Gastroduodenal Diseases in Japan</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tahara</surname><given-names>Tomomitsu</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Arisawa</surname><given-names>Tomiyasu</given-names></name></contrib><contrib contrib-type="author"><name><surname>Shibata</surname><given-names>Tomoyuki</given-names></name></contrib><contrib contrib-type="author"><name><surname>Hirata</surname><given-names>Ichiro</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nakano</surname><given-names>Hiroshi</given-names></name></contrib></contrib-group><aff id="aff1">Department of Gastroenterology, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan</aff><author-notes><corresp id="cor1">*To whom correspondence should be addressed. Tel: +81-562-93-9240 Fax: +81-562-93-8300 E-mail: <email>tomomiccyu@yahoo.co.jp</email></corresp></author-notes><pub-date pub-type="ppub"><month>1</month><year>2007</year></pub-date><pub-date pub-type="epub"><day>27</day><month>12</month><year>2006</year></pub-date><volume>40</volume><issue>1</issue><fpage>62</fpage><lpage>65</lpage><history><date date-type="received"><day>24</day><month>7</month><year>2006</year></date><date date-type="accepted"><day>22</day><month>8</month><year>2006</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2006 JCBN</copyright-statement><copyright-year>2006</copyright-year><license license-type="open-access"><p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>Host genetic factors may play a key role in determining the long-term outcome of the <italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) infection. Toll-like receptor 4 (TLR4) mediated recognition of lipo-polysaccharide (LPS) is required for efficient recognition of gram-negative bacterial infections. The aim of this study is to investigate the effects of common polymorphisms of TLR4 Asp299Gly, Thr399Ile in patients with gastroduodenal diseases in Japanese population. The study was performed in 149 gastric cancer (GC) cases (mean age 64.0&#x000a0;&#x000b1;&#x000a0;12.4, M:F&#x000a0;=&#x000a0;109:40) and 94 patients without evidence of GC (mean age 64.1&#x000a0;&#x000b1;&#x000a0;12.3, M:F&#x000a0;=&#x000a0;65:25) as the control group. TLR4 Asp299Gly, Thr399Ile were determined by Polymerase chain reaction-length of polymorphisms (PCR-RFLP) in all the patients. Asp299Gly, Thr399Ile were not detected in all 243 patients enrolled in this study. In conclusion, our data suggest that TLR4 Asp299Gly, Thr399Ile are very rare in Japanese population and thus they may not be a important factor in determining the outcome of <italic>H. pylori</italic> infected individuals in Japan.</p></abstract><kwd-group><kwd>gastric cancer</kwd><kwd><italic>Helicobacter pylori</italic></kwd><kwd>toll-like receptor 4</kwd><kwd>polymorphism</kwd></kwd-group></article-meta></front><body><sec sec-type="introduction"><title>Introduction</title><p><italic>Helicobacter pylori</italic> (<italic>H. pylori</italic>) infection is now accepted as a crucial event in the development of peptic ulcer disease and atrophic gastritis, and it is implicated in the development of gastric carcinoma [<xref ref-type="bibr" rid="B1">1</xref>&#x02013;<xref ref-type="bibr" rid="B5">5</xref>]. However, there are distinct differences in the extent of gastric mucosal inflammation and atrophy among <italic>H. pylori</italic> infected patients, and only a small group of them develop peptic ulcer disease and gastric cancer. It suggests that some genetic factors may play important roles in long term outcome of <italic>H. pylori</italic> infection [<xref ref-type="bibr" rid="B6">6</xref>].</p><p>Toll-like receptor 4 (TLR4) is important mediator of the inflammatory response in the first line of host defense by recognition of Lipopolysaccharide (LPS) [<xref ref-type="bibr" rid="B7">7</xref>&#x02013;<xref ref-type="bibr" rid="B9">9</xref>]. LPS, a major component of the outer cell wall of gram-negative bacteria, is a potent and well-characterized inducer of inflammation. After forming a complex with the LPS- binding protein, LPS interacts with a membrane molecule, CD14 and MD2 [<xref ref-type="bibr" rid="B10">10</xref>&#x02013;<xref ref-type="bibr" rid="B12">12</xref>]. Together with TLR4, this complex induces second-messenger and signal transduction pathways [<xref ref-type="bibr" rid="B13">13</xref>]. These signals in turn activate transcription factors, mainly nuclear factor-&#x003ba;B (NF&#x003ba;B) and cytokines [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B14">14</xref>].</p><p>Recently it was reported that TLR4 expression by gastric epithelium was more stronger in <italic>H. pylori</italic> gastritis than in the non in inflamed gastric mucosa [<xref ref-type="bibr" rid="B15">15</xref>]. It was also reported that TLR4 regulated the response of gastric epithelial cells to <italic>H. pylori</italic> infection and <italic>H. pylori</italic> LPS-induced transcription of several genes depends on the activation of NF&#x003ba;B [<xref ref-type="bibr" rid="B16">16</xref>]. These findings support a sentinel role for TLR4 in the mucosal immunity to <italic>H. pylori.</italic></p><p>Genetic studies of TLR4 have identified polymorphisms. Arbour <italic>et al</italic>. [<xref ref-type="bibr" rid="B17">17</xref>] demonstrated 2 cosegregating polymorphisms in the extracellular domain of the TLR4 gene. The first is an A-G substitution at nucleotide 896 from the start codon of the TLR4 gene, which results in an aspartic acid-to-glycine substitution at position 299 of the amino acid sequence (Asp299Gly). A cosegregating polymorphism that results in a thereonine-to-isoleucine substitution at position 399 of the amino acid sequence (Thr399Ile) also was identified. These polymorphisms are associated with functional changes, as demonstrated by decreased airway responsiveness after LPS stimulation [<xref ref-type="bibr" rid="B18">18</xref>].</p><p>Because of the important roles that TLR4 play with respect to LPS binding and signaling, we hypothesized that polymorphisms in the TLR4 gene may be important factors for determining the long term outcome of the <italic>H. pylori</italic> infection.</p><p>In the present study, we investigated the effects of TLR4 (Asp299Gly, Thr399Ile) polymorphisms on gastroduodenal diseases in Japanese population.</p></sec><sec sec-type="subjects and methods"><title>Subjects and Methods</title><sec><title>Study Population</title><p>We studied 243 patients attending the gastroenterology division of Fujita Health University Hospital (Aichi, Japan) from January 2005 to January 2006. Gastroscopy was done in all of the patients and they were divided into two groups for assessment of TLR4 polymorphisms. There were 149 gastric cancer (GC) patients with a mean age of 64.0 (29&#x02013;91) years and a male:female (M:F) ratio of 109:40 and 94 patients with no evidence of GC (mean age of 64.1 [30&#x02013;90] years old and M:F&#x000a0;=&#x000a0;65:29) as the control group. GC was diagnosed histologically and was classified according to Lauren&#x02019;s classification [<xref ref-type="bibr" rid="B18">18</xref>]. Detailed information was obtained about staging and anatomic location (Table&#x000a0;<xref ref-type="table" rid="T1">1</xref>). The Ethics Committee of Fujita Health University School of Medicine approved the protocol and written informed consent was obtained from all of the subjects.</p></sec><sec><title>Detection of H. pylori</title><p><italic>H. pylori</italic> infection status was determined by histology, culture, the rapid urease test (RUT), or the serum titer of antibodies against <italic>H. pylori.</italic> Infection was diagnosed when at least one of these tests was positive.</p></sec><sec><title>Genotyping</title><p>Genomic DNA was extracted from non-cancerous gastric biopsy tissue or peripheral blood using the standard phenol/chloroform method. Then Asp299Gly, Thr399Ile polymorphisms of TLR4 were determined using PCR and subsequent cleavage by NcoI and HinfI restriction endnucleases as previously described [<xref ref-type="bibr" rid="B19">19</xref>].</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Study population</title><p>A total of 149 GC patients and 94 control subjects without evidence of GC participated in this study. Their characteristics are summarized in Table&#x000a0;<xref ref-type="table" rid="T2">2</xref>. There were no significant differences between these groups in the distribution of age and sex, but the <italic>H. pylori </italic>infection rate was significantly higher in the GC patients (<italic>p</italic>&#x000a0;=&#x000a0;0.0002). The control group included 25 patients gastric ulcer (26.7%), 7 patients with duodenal ulcer (7.4%) and patients with gastric&#x000a0;+&#x000a0;duodenal ulcer (2.1%). They were all <italic>H. pylori</italic> positives.</p></sec><sec><title>TLR4 genotypes</title><p>Asp299Gly, Thr399Ile polymorphisms of TLR4 were typed in all 243 subjects. However, in this study, Asp299Gly and Thr399Ile polymorphisms of TLR4 were not detected in all the 243 subjects.</p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p><italic>H. pylori</italic> LPS has not been considered to play a major role in the pathogenesis of gastritis because its biological activity is lower than that of the LPS of pathogens such as <italic>Escherichia coli</italic> (<italic>E.coli</italic>) and <italic>Salmonella</italic><italic>species</italic> (<italic>Salmonella spp</italic>) [<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B21">21</xref>]. But in contrast, several studies have demonstrated significant roles of <italic>H. pylori</italic> LPS in the induction of gastritis. Teshima <italic>et al.</italic> [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>] have shown that <italic>H. pylori</italic> LPS stimulates NF-&#x003ba;B activation markedly in cultured guinea pig gastric mucosal cells and leads to abundant release of superoxide anion from the cells. In addition, the severity of atrophic gastritis induced by long term infection of <italic>Haemobartonella felis</italic> in CH3/He mice is significantly higher than that in LPS-non responder CH3/HeJ mice [<xref ref-type="bibr" rid="B24">24</xref>], which have an inactivating point mutation in TLR4 [<xref ref-type="bibr" rid="B25">25</xref>]. More recently, Karhukorpi <italic>et al</italic>. [<xref ref-type="bibr" rid="B26">26</xref>] reported elevated serum levels of a soluble form of the CD14 molecule in <italic>H. pylori</italic> infected individuals. Soluble CD14 binds to LPS and facilitates its signaling, and this study has shown that CD14 promoter polymorphism is associated with the disease outcome. All of these findings suggest that <italic>H. pylori</italic> LPS may be a potent mediator in modulating <italic>H. pylori</italic> infection induced gastritis and it may be reasonable to speculate that inter individual difference of innate immune response to <italic>H. pylori</italic> LPS is a important factor in determining the long term out come of the <italic>H. pylori</italic> infection.</p><p>TLR4-mediated recognition of LPS is required for efficient recognition of Gram-negative bacterial infections and some studies shows important roles that TLR4 plays with respect to LPS binding and signaling even in <italic>H. pylori</italic> infection [<xref ref-type="bibr" rid="B16">16</xref>].</p><p>In 2000, Arbor <italic>et al.</italic> reported that TLR4 polymorphisms Asp299Gly, Thr399Ile lead to a LPS-hyporesponsive phenotype in either human primary airway epithelial cells or alveolar macrophages [<xref ref-type="bibr" rid="B17">17</xref>]. Concerning host genetic factors, polymorphisms in TLR4 show an increased risk to develop a septic shock with gram negative microorganisms [<xref ref-type="bibr" rid="B27">27</xref>], premature birth [<xref ref-type="bibr" rid="B28">28</xref>], graft versus host disease after hematopoietic stem cell transplantation [<xref ref-type="bibr" rid="B29">29</xref>], and inflammatory bowel disease [<xref ref-type="bibr" rid="B30">30</xref>]. But in this study, we did not detect 299Gly or 399Ile alleles in patients with gastroduodenal diseases in Japanese population. All 243 subjects did not have 299Gly and 399Ile polymorphisms of TLR4. Noguchi <italic>et al</italic>. screened 32 Japanese asthmatics and did not detect 299Gly or 399Ile polymorphisms of TLR4 [<xref ref-type="bibr" rid="B31">31</xref>]. Similar results has also been reported in other studies in China [<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>]. 299Gly and 399Ile polymorphisms of TLR4 may be very rare at least in Japanese and Chinese population and thus may not be an important factor in determining the outcome of the <italic>H. pylori</italic> infected patients in this area. Recently, Ohara <italic>et al.</italic> reported the potential association between TLR4 Thr 135 Ala polymorphism at leucine-rich repeat (LRR) of toll-like receptor 4 and risk of diffuse type gastric cancer in Japanese population [<xref ref-type="bibr" rid="B34">34</xref>]. This polymorphism but not 299Gly or 399Ile may influence the function of TLR4 and modify the risk of <italic>H. pylori</italic> related gastrodduodenal diseases in Japanese population.</p><p>In conclusion, we have shown that 299Gly and 399Ile polymorphisms of TLR4 are very rare in patients with gastroduodenal diseases in Japan. Further genetic studies will be needed to resolve the impact of the TLR4 polymorphisms in the susceptibility of gastroduodenal diseases in Japanese population.</p></sec></body><back><ref-list><title>References</title><ref id="B1"><label>1</label><citation citation-type="journal"><collab>NIH Consensus Conference</collab><article-title><italic>Helicobacter pylori</italic> in peptic ulcer disease. NIH Consensus Development Panel on <italic>Helicobacter pylori</italic> in Peptic Ulcer Disease</article-title><source><italic>JAMA</italic></source><volume>272</volume><fpage>65</fpage><lpage>69</lpage><year>1994</year><pub-id pub-id-type="pmid">8007082</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Uemura</surname><given-names>N.</given-names></name><name><surname>Okamoto</surname><given-names>S.</given-names></name><name><surname>Yamamoto</surname><given-names>S.</given-names></name><name><surname>Matsumura</surname><given-names>N.</given-names></name><name><surname>Yamaguchi</surname><given-names>S.</given-names></name><name><surname>Yamakido</surname><given-names>M.</given-names></name><name><surname>Taniyama</surname><given-names>K.</given-names></name><name><surname>Sasaki</surname><given-names>N.</given-names></name><name><surname>Schlemper</surname><given-names>R.J.</given-names></name></person-group><article-title>Helicobacter pylori infection and the development of gastric cancer</article-title><source>N. Engl. J. Med.</source><volume>345</volume><fpage>784</fpage><lpage>789</lpage><year>2001</year><pub-id pub-id-type="pmid">11556297</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parsonnet</surname><given-names>J.</given-names></name><name><surname>Friedman</surname><given-names>G.D.</given-names></name><name><surname>Vandersteen</surname><given-names>D.P.</given-names></name><name><surname>Chang</surname><given-names>Y.</given-names></name><name><surname>Vogelman</surname><given-names>J.H.</given-names></name><name><surname>Orentreich</surname><given-names>N.</given-names></name><name><surname>Sibley</surname><given-names>RK.</given-names></name></person-group><article-title><italic>Helicobacter pylori</italic> infection and the risk of gastric carcinoma</article-title><source> N. Engl. J. Med.</source><volume>325</volume><fpage>1127</fpage><lpage>1131</lpage><year>1991</year><pub-id pub-id-type="pmid">1891020</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J.Q.</given-names></name><name><surname>Sridhar</surname><given-names>S.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Hunt</surname><given-names>R.H.</given-names></name></person-group><article-title>Meta-analysis of the relationship between <italic>Helicobacter pylori</italic> seropositivity and gastric cancer</article-title><source>Gastroenterology</source><volume>114</volume><fpage>1169</fpage><lpage>1179</lpage><year>1998</year><pub-id pub-id-type="pmid">9609753</pub-id></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blaser</surname><given-names>M.J.</given-names></name><name><surname>Parsonnet</surname><given-names>J.</given-names></name></person-group><article-title>Parasitism by the &#x0201c;slow&#x0201d; bacterium <italic>Helicobacter pylori</italic> leads to altered gastric homeostasis and neoplasia</article-title><source>J. Clin. Invest.</source><volume>94</volume><fpage>4</fpage><lpage>8</lpage><year>1994</year><pub-id pub-id-type="pmid">8040281</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naito</surname><given-names>Y.</given-names></name><name><surname>Yoshikawa</surname><given-names>T.</given-names></name></person-group><article-title>Carcinogenesis and chemoprevention in gastric cancer associated with <italic>Helicobacter pylori</italic> infection: role of oxidants and antioxidants</article-title><source>J. Clin. Biochem. Nutr.</source><volume>36</volume><fpage>37</fpage><lpage>49</lpage><year>2005</year></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lemaitre</surname><given-names>B.</given-names></name><name><surname>Nicolas</surname><given-names>E.</given-names></name><name><surname>Michaut</surname><given-names>L.</given-names></name><name><surname>Reichhart</surname><given-names>J.M.</given-names></name><name><surname>Hoffmann</surname><given-names>J.A.</given-names></name></person-group><article-title>The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults</article-title><source>Cell</source><volume>86</volume><fpage>973</fpage><lpage>983</lpage><year>1996</year><pub-id pub-id-type="pmid">8808632</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beutler</surname><given-names>B.</given-names></name></person-group><article-title>Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity</article-title><source>Curr. Opin. Microbiol.</source><volume>3</volume><fpage>23</fpage><lpage>28</lpage><year>2000</year><pub-id pub-id-type="pmid">10679425</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Beutler</surname><given-names>B.</given-names></name></person-group><article-title>Tlr4: central component of the sole mammalian LPS sensor</article-title><source>Curr. Opin. Immunol.</source><volume>12</volume><fpage>20</fpage><lpage>26</lpage><year>2000</year><pub-id pub-id-type="pmid">10679411</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ulevitch</surname><given-names>R.J.</given-names></name><name><surname>Tobias</surname><given-names>P.S.</given-names></name></person-group><article-title>Receptor-dependent mechanisms of cell stimulation by bacterial endotoxin</article-title><source>Annu. Rev. Immunol.</source><volume>13</volume><fpage>437</fpage><lpage>457</lpage><year>1995</year><pub-id pub-id-type="pmid">7542010</pub-id></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>S.D.</given-names></name><name><surname>Ramos</surname><given-names>R.A.</given-names></name><name><surname>Tobias</surname><given-names>P.S.</given-names></name><name><surname>Ulevitch</surname><given-names>R.J.</given-names></name><name><surname>Mathison</surname><given-names>J.C.</given-names></name></person-group><article-title>CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein</article-title><source>Science</source><volume>249</volume><fpage>1431</fpage><lpage>1433</lpage><year>1990</year><pub-id pub-id-type="pmid">1698311</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>da Silva Correia</surname><given-names>J.</given-names></name><name><surname>Soldau</surname><given-names>K.</given-names></name><name><surname>Christen</surname><given-names>U.</given-names></name><name><surname>Tobias</surname><given-names>P.S.</given-names></name><name><surname>Ulevitch</surname><given-names>R.J.</given-names></name></person-group><article-title>Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2</article-title><source>J. Biol. Chem.</source><volume>276</volume><fpage>21129</fpage><lpage>21135</lpage><year>2001</year><pub-id pub-id-type="pmid">11274165</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Janeway</surname><given-names>C.A.</given-names><suffix>Jr.</suffix></name><name><surname>Medzhitov</surname><given-names>R.</given-names></name></person-group><article-title>Introduction: the role of innate immunity in the adaptive immune response</article-title><source>Semin. Immunol.</source><volume>10</volume><fpage>349</fpage><lpage>350</lpage><year>1998</year><pub-id pub-id-type="pmid">9799708</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sweet</surname><given-names>M.J.</given-names></name><name><surname>Hume</surname><given-names>D.A.</given-names></name></person-group><article-title>Endotoxin signal transduction in macrophages</article-title><source>J. Leukoc. Biol.</source><volume>60</volume><fpage>8</fpage><lpage>26</lpage><year>1996</year><pub-id pub-id-type="pmid">8699127</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmausse</surname><given-names>B.</given-names></name><name><surname>Andrulis</surname><given-names>M.</given-names></name><name><surname>Endrich</surname><given-names>S.</given-names></name><name><surname>Lee</surname><given-names>S.K.</given-names></name><name><surname>Josenhans</surname><given-names>C.</given-names></name><name><surname>Muller-Hermelink</surname><given-names>H.K.</given-names></name><name><surname>Eck</surname><given-names>M.</given-names></name></person-group><article-title>Expression and subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9 on the gastric epithelium in <italic>Helicobacter pylori</italic> infection</article-title><source>Clin. Exp. Immunol.</source><volume>136</volume><fpage>521</fpage><lpage>526</lpage><year>2004</year><pub-id pub-id-type="pmid">15147355</pub-id></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kawahara</surname><given-names>T.</given-names></name><name><surname>Kuwano</surname><given-names>Y.</given-names></name><name><surname>Teshima-Kondo</surname><given-names>S.</given-names></name><name><surname>Kawai</surname><given-names>T.</given-names></name><name><surname>Nikawa</surname><given-names>T.</given-names></name><name><surname>Kishi</surname><given-names>K.</given-names></name><name><surname>Rokutan</surname><given-names>K.</given-names></name></person-group><article-title>Toll-like receptor 4 regulates gastric pit cell responses to <italic>Helicobacter pylori</italic> infection</article-title><source>J. Med. Invest.</source><volume>48</volume><fpage>190</fpage><lpage>197</lpage><year>2001</year><pub-id pub-id-type="pmid">11694959</pub-id></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arbour</surname><given-names>N.C.</given-names></name><name><surname>Lorenz</surname><given-names>E.</given-names></name><name><surname>Schutte</surname><given-names>B.C.</given-names></name><name><surname>Zabner</surname><given-names>J.</given-names></name><name><surname>Kline</surname><given-names>J.N.</given-names></name><name><surname>Jones</surname><given-names>M.</given-names></name><name><surname>Frees</surname><given-names>K.</given-names></name><name><surname>Watt</surname><given-names>J.L.</given-names></name><name><surname>Schwartz</surname><given-names>D.A.</given-names></name></person-group><article-title>TLR4 mutations are associated with endotoxin hypozresponsiveness in humans</article-title><source>Nat. Genet.</source><volume>25</volume><fpage>187</fpage><lpage>191</lpage><year>2000</year><pub-id pub-id-type="pmid">10835634</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lauren</surname><given-names>P.</given-names></name></person-group><article-title>The two histrogical main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification</article-title><source>Acta. Pathol. Microbiol. Scand.</source><volume>64</volume><fpage>31</fpage><lpage>49</lpage><year>1965</year><pub-id pub-id-type="pmid">14320675</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>E.</given-names></name><name><surname>Frees</surname><given-names>K.L.</given-names></name><name><surname>Schwartz</surname><given-names>D.A.</given-names></name></person-group><article-title>Determination of the TLR4 genotype using allele-specific PCR</article-title><source>Biotechniques</source><volume>31</volume><fpage>22</fpage><lpage>24</lpage><year>2001</year><pub-id pub-id-type="pmid">11464514</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Birkholz</surname><given-names>S.</given-names></name><name><surname>Knipp</surname><given-names>U.</given-names></name><name><surname>Nietzki</surname><given-names>C.</given-names></name><name><surname>Adamek</surname><given-names>R.J.</given-names></name><name><surname>Opferkuch</surname><given-names>W.</given-names></name></person-group><article-title>Immunological activity of lipopolysaccharide of <italic>Helicobacter pylori</italic> on human peripheral mononuclear blood cells in comparison to lipopolysaccharides of other intestinal bacteria</article-title><source>FEMS. Immunol. Med. Microbiol.</source><volume>6</volume><fpage>317</fpage><lpage>324</lpage><year>1993</year><pub-id pub-id-type="pmid">8499895</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Perez-Perez</surname><given-names>G.I.</given-names></name><name><surname>Shepherd</surname><given-names>V.L.</given-names></name><name><surname>Morrow</surname><given-names>J.D.</given-names></name><name><surname>Blaser</surname><given-names>M.J.</given-names></name></person-group><article-title>Activation of human THP-1 cells and rat bone marrow-derived macrophages by <italic>Helicobacter pylori</italic> lipopolysaccharide</article-title><source>Infect. Immun.</source><volume>63</volume><fpage>1183</fpage><lpage>1187</lpage><year>1995</year><pub-id pub-id-type="pmid">7890370</pub-id></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teshima</surname><given-names>S.</given-names></name><name><surname>Tsunawaki</surname><given-names>S.</given-names></name><name><surname>Rokutan</surname><given-names>K.</given-names></name></person-group><article-title><italic>Helicobacter pylori</italic> lipopolysaccharide enhances the expression of NADPH oxidase components in cultured guinea pig gastric mucosal cells</article-title><source>FEBS. Lett.</source><volume>452</volume><fpage>243</fpage><lpage>246</lpage><year>1999</year><pub-id pub-id-type="pmid">10386599</pub-id></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Teshima</surname><given-names>S.</given-names></name><name><surname>Rokutan</surname><given-names>K.</given-names></name><name><surname>Nikawa</surname><given-names>T.</given-names></name><name><surname>Kishi</surname><given-names>K.</given-names></name></person-group><article-title>Guinea pig gastric mucosal cells produce abundant superoxide anion through an NADPH oxidase-like system</article-title><source>Gastroenterology</source><volume>115</volume><fpage>1186</fpage><lpage>1196</lpage><year>1998</year><pub-id pub-id-type="pmid">9797374</pub-id></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sakagami</surname><given-names>T.</given-names></name><name><surname>Vella</surname><given-names>J.</given-names></name><name><surname>Dixon</surname><given-names>M.F.</given-names></name><name><surname>O&#x02019;Rourke</surname><given-names>J.</given-names></name><name><surname>Radcliff</surname><given-names>F.</given-names></name><name><surname>Sutton</surname><given-names>P.</given-names></name><name><surname>Shimoyama</surname><given-names>T.</given-names></name><name><surname>Beagley</surname><given-names>K.</given-names></name><name><surname>Lee</surname><given-names>A.</given-names></name></person-group><article-title>The endotoxin of <italic>Helicobacter pylori</italic> is a modulator of host-dependent gastritis</article-title><source>Infect. Immun.</source><volume>65</volume><fpage>3310</fpage><lpage>3316</lpage><year>1997</year><pub-id pub-id-type="pmid">9234792</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Poltorak</surname><given-names>A.</given-names></name><name><surname>He</surname><given-names>X.</given-names></name><name><surname>Smirnova</surname><given-names>I.</given-names></name><name><surname>Liu</surname><given-names>M.Y.</given-names></name><name><surname>Van Huffel</surname><given-names>C.</given-names></name><name><surname>Du</surname><given-names>X.</given-names></name><name><surname>Birdwell</surname><given-names>D.</given-names></name><name><surname>Alejos</surname><given-names>E.</given-names></name><name><surname>Silva</surname><given-names>M.</given-names></name><name><surname>Galanos</surname><given-names>C.</given-names></name><name><surname>Freudenberg</surname><given-names>M.</given-names></name><name><surname>Ricciardi-Castagnoli</surname><given-names>P.</given-names></name><name><surname>Layton</surname><given-names>B.</given-names></name><name><surname>Beutler</surname><given-names>B.</given-names></name></person-group><article-title>Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene</article-title><source>Science</source><volume>282</volume><fpage>2085</fpage><lpage>2088</lpage><year>1998</year><pub-id pub-id-type="pmid">9851930</pub-id></citation></ref><ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karhukorpi</surname><given-names>J.</given-names></name><name><surname>Yan</surname><given-names>Y.</given-names></name><name><surname>Niemela</surname><given-names>S.</given-names></name><name><surname>Valtonen</surname><given-names>J.</given-names></name><name><surname>Koistinen</surname><given-names>P.</given-names></name><name><surname>Joensuu</surname><given-names>T.</given-names></name><name><surname>Saikku</surname><given-names>P.</given-names></name><name><surname>Karttunen</surname><given-names>R.</given-names></name></person-group><article-title>Effect of CD14 promoter polymorphism and <italic>H. pylori</italic> infection and its clinical outcomes on circulating CD14</article-title><source>Clin. Exp. Immunol.</source><volume>128</volume><fpage>326</fpage><lpage>322</lpage><year>2002</year><pub-id pub-id-type="pmid">11985523</pub-id></citation></ref><ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>E.</given-names></name><name><surname>Mira</surname><given-names>J.P.</given-names></name><name><surname>Frees</surname><given-names>K.L.</given-names></name><name><surname>Schwartz</surname><given-names>D.A.</given-names></name></person-group><article-title>Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock</article-title><source>Arch. Intern. Med.</source><volume>162</volume><fpage>1028</fpage><lpage>32</lpage><year>2002</year><pub-id pub-id-type="pmid">11996613</pub-id></citation></ref><ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>E.</given-names></name><name><surname>Hallman</surname><given-names>M.</given-names></name><name><surname>Marttila</surname><given-names>R.</given-names></name><name><surname>Haataja</surname><given-names>R.</given-names></name><name><surname>Schwartz</surname><given-names>D.A.</given-names></name></person-group><article-title>Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population</article-title><source>Pediatr. Res.</source><volume>52</volume><fpage>373</fpage><lpage>376</lpage><year>2002</year><pub-id pub-id-type="pmid">12193670</pub-id></citation></ref><ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lorenz</surname><given-names>E.</given-names></name><name><surname>Schwartz</surname><given-names>D.A.</given-names></name><name><surname>Martin</surname><given-names>P.J.</given-names></name><name><surname>Gooley</surname><given-names>T.</given-names></name><name><surname>Lin</surname><given-names>M.T.</given-names></name><name><surname>Chien</surname><given-names>J.W.</given-names></name><name><surname>Hansen</surname><given-names>J.A.</given-names></name><name><surname>Clark</surname><given-names>J.G.</given-names></name></person-group><article-title>Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation</article-title><source>Biol. Blood. Marrow. Transplant.</source><volume>7</volume><fpage>384</fpage><lpage>387</lpage><year>2001</year><pub-id pub-id-type="pmid">11529488</pub-id></citation></ref><ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franchimont</surname><given-names>D.</given-names></name><name><surname>Vermeire</surname><given-names>S.</given-names></name><name><surname>El Housni</surname><given-names>H.</given-names></name><name><surname>Pierik</surname><given-names>M.</given-names></name><name><surname>Van Steen</surname><given-names>K.</given-names></name><name><surname>Gustot</surname><given-names>T.</given-names></name><name><surname>Quertinmont</surname><given-names>E.</given-names></name><name><surname>Abramowicz</surname><given-names>M.</given-names></name><name><surname>Van Gossum</surname><given-names>A.</given-names></name><name><surname>Deviere</surname><given-names>J.</given-names></name><name><surname>Rutgeerts</surname><given-names>P.</given-names></name></person-group><article-title>Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn&#x02019;s disease and ulcerative colitis</article-title><source>Gut</source><volume>53</volume><fpage>987</fpage><lpage>992</lpage><year>2004</year><pub-id pub-id-type="pmid">15194649</pub-id></citation></ref><ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noguchi</surname><given-names>E.</given-names></name><name><surname>Nishimura</surname><given-names>F.</given-names></name><name><surname>Fukai</surname><given-names>H.</given-names></name><name><surname>Kim</surname><given-names>J.</given-names></name><name><surname>Ichikawa</surname><given-names>K.</given-names></name><name><surname>Shibasaki</surname><given-names>M.</given-names></name><name><surname>Arinami</surname><given-names>T.</given-names></name></person-group><article-title>An association study of asthma and total serum immunoglobin E levels for Toll-like receptor polymorphisms in a Japanese population</article-title><source>Clin. Exp. Allergy.</source><volume>34</volume><fpage>177</fpage><lpage>183</lpage><year>2004</year><pub-id pub-id-type="pmid">14987294</pub-id></citation></ref><ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>Y.C.</given-names></name><name><surname>Chang</surname><given-names>Y.M.</given-names></name><name><surname>Yu</surname><given-names>J.M.</given-names></name><name><surname>Yen</surname><given-names>J.H.</given-names></name><name><surname>Chang</surname><given-names>J.G.</given-names></name><name><surname>Hu</surname><given-names>C.J.</given-names></name></person-group><article-title>Toll-like receptor 4 gene C119A but not Asp299Gly polymorphism is associated with ischemic stroke among ethnic Chinese in Taiwan</article-title><source>Atherosclerosis</source><volume>180</volume><fpage>305</fpage><lpage>309</lpage><year>2005</year><pub-id pub-id-type="pmid">15910856</pub-id></citation></ref><ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hang</surname><given-names>J.</given-names></name><name><surname>Zhou</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Sun</surname><given-names>B.</given-names></name><name><surname>Dai</surname><given-names>H.</given-names></name><name><surname>Su</surname><given-names>L.</given-names></name><name><surname>Christiani</surname><given-names>D.C.</given-names></name></person-group><article-title>TLR4 Asp299Gly and Thr399Ile polymorphisms are very rare in the Chinese population</article-title><source>J. Endotoxin Res.</source><volume>10</volume><fpage>238</fpage><lpage>240</lpage><year>2004</year><pub-id pub-id-type="pmid">15373967</pub-id></citation></ref><ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohara</surname><given-names>T.</given-names></name><name><surname>Morishita</surname><given-names>T.</given-names></name><name><surname>Suzuki</surname><given-names>H.</given-names></name><name><surname>Hibi</surname><given-names>Y.</given-names></name></person-group><article-title>Heterozygous Thr 135 Ala polymorphism at leucine-rich repeat (LRR) in genomic DNA of toll-like receptor 4 in patients with poorly-differentiated gastric adenocarcinomas</article-title><source>Int. J. Mol. Med.</source><volume>18</volume><fpage>59</fpage><lpage>63</lpage><year>2006</year><pub-id pub-id-type="pmid">16786156</pub-id></citation></ref></ref-list></back><floats-wrap><table-wrap id="T1" position="float"><label>Table&#x000a0;1</label><caption><p>Clinicopathologic characteristics of GC</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" rowspan="1" colspan="1">Variables (n)</th><th rowspan="1" colspan="1"/></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Histrogic subtypes</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Intestinal type</td><td align="right" rowspan="1" colspan="1">85</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Diffuse type</td><td align="right" rowspan="1" colspan="1">64</td></tr><tr><td align="left" rowspan="1" colspan="1">Tumor location</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Cardia</td><td align="right" rowspan="1" colspan="1">6</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Non cardia</td><td align="right" rowspan="1" colspan="1">143</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Upper third</td><td align="right" rowspan="1" colspan="1">4</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Middle third</td><td align="right" rowspan="1" colspan="1">84</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Lower third</td><td align="right" rowspan="1" colspan="1">55</td></tr><tr><td align="left" rowspan="1" colspan="1">Tumor stage</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Early stage</td><td align="right" rowspan="1" colspan="1">62</td></tr><tr><td align="left" rowspan="1" colspan="1">&#x02003;Advanced stage</td><td align="right" rowspan="1" colspan="1">73</td></tr></tbody></table></table-wrap><table-wrap id="T2" position="float"><label>Table&#x000a0;2</label><caption><p>Characteristics of subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"/><th align="center" rowspan="1" colspan="1">Gastric cancer (GC) cases</th><th align="center" rowspan="1" colspan="1">Patients without GC</th><th align="center" valign="middle" rowspan="1" colspan="1"><italic>p</italic></th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Subjects (n)</td><td align="center" rowspan="1" colspan="1">149</td><td align="center" rowspan="1" colspan="1">104</td><td rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Sex [male/female (%/%)]</td><td align="center" valign="middle" rowspan="1" colspan="1">109/40 (73/27)</td><td align="center" valign="middle" rowspan="1" colspan="1">65/29 (69/31)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.53<xref ref-type="table-fn" rid="tblfn2">$</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Mean age&#x000a0;&#x000b1;&#x000a0;SD (y)</td><td align="center" rowspan="1" colspan="1">64.0&#x000a0;&#x000b1;&#x000a0;12.4</td><td align="center" rowspan="1" colspan="1">64.1&#x000a0;&#x000b1;&#x000a0;12.3</td><td align="center" rowspan="1" colspan="1">0.76<xref ref-type="table-fn" rid="tblfn1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"><italic>H. pylori</italic> infection positive ratio (%)</td><td align="center" valign="middle" rowspan="1" colspan="1">90.6</td><td align="center" valign="middle" rowspan="1" colspan="1">72.3</td><td align="center" valign="middle" rowspan="1" colspan="1">0.002<xref ref-type="table-fn" rid="tblfn2">$</xref></td></tr></tbody></table><table-wrap-foot><fn id="tblfn1"><label>$</label><p><italic>x</italic><sup>2</sup> test, </p></fn><fn id="tblfn2"><label>*</label><p>Mann-Whitney U test</p></fn></table-wrap-foot></table-wrap></floats-wrap></article> 